| Product Code: ETC7656984 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neuropathic Pain Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neuropathic Pain Market - Industry Life Cycle |
3.4 Israel Neuropathic Pain Market - Porter's Five Forces |
3.5 Israel Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Israel Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Israel Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Israel Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Israel Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Israel Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Israel Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuropathic pain in Israel |
4.2.2 Growing awareness about treatment options for neuropathic pain |
4.2.3 Technological advancements in pain management therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neuropathic pain treatments |
4.3.2 High cost associated with neuropathic pain medications and treatments |
5 Israel Neuropathic Pain Market Trends |
6 Israel Neuropathic Pain Market, By Types |
6.1 Israel Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Israel Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Israel Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Israel Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Israel Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Israel Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Israel Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Israel Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Israel Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Israel Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Israel Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Israel Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Israel Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Israel Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Israel Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Israel Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Israel Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Israel Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Israel Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Israel Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Israel Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Israel Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Israel Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Israel Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Israel Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Israel Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Israel Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Israel Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Israel Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Israel Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Israel Neuropathic Pain Market Export to Major Countries |
7.2 Israel Neuropathic Pain Market Imports from Major Countries |
8 Israel Neuropathic Pain Market Key Performance Indicators |
8.1 Patient-reported pain relief and improvement in quality of life |
8.2 Number of clinical trials and research studies focused on neuropathic pain in Israel |
8.3 Adoption rate of non-pharmacological pain management techniques in the healthcare system |
9 Israel Neuropathic Pain Market - Opportunity Assessment |
9.1 Israel Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Israel Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Israel Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Israel Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Israel Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Israel Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Israel Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Israel Neuropathic Pain Market - Competitive Landscape |
10.1 Israel Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Israel Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here